AtriCure (NASDAQ:ATRC) Price Target Cut to $46.00 by Analysts at JPMorgan Chase & Co.
AtriCure (NASDAQ:ATRC – Free Report) had its target price decreased by JPMorgan Chase & Co. from $51.00 to $46.00 in a ...